HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exacerbation of human cataplexy by prazosin.

Abstract
A middle-aged woman with narcolepsy developed a pronounced exacerbation of cataplexy within 3 days of beginning treatment for hypertension with prazosin, an alpha 1-adrenoceptor antagonist. At times, episodes of cataplexy were virtually continuous (status cataplecticus), and there was only partial amelioration with tricyclic antidepressants. Cataplexy improved when prazosin was discontinued. These findings are similar to the reported effects of prazosin on cataplexy in narcoleptic dogs; they support a role for altered alpha 1-adrenoceptor function in narcolepsy.
AuthorsM S Aldrich, A E Rogers
JournalSleep (Sleep) Vol. 12 Issue 3 Pg. 254-6 (Jun 1989) ISSN: 0161-8105 [Print] United States
PMID2740697 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Prazosin
Topics
  • Cataplexy (chemically induced)
  • Female
  • Hallucinations (chemically induced)
  • Humans
  • Hypertension (drug therapy)
  • Middle Aged
  • Prazosin (adverse effects, therapeutic use)
  • Sleep Stages (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: